[S,S]-Reboxetine Long Term Safety Study In Post-Shingles Pain.
NCT00354094
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
600
Enrollment
INDUSTRY
Sponsor class
Stopped
The study was stopped due to business/operational issues.
Conditions
Pain
Interventions
DRUG:
[S,S]-Reboxetine
Sponsor
Pfizer